首页> 外文期刊>European urology >Corrigendum to 'The Effects of Combination Therapy with Dutasteride and Tamsulosin on Clinical Outcomes in Men with Symptomatic Benign Prostatic Hyperplasia: 4-Year Results from the CombAT Study' (Eur Urol 2010;57:123-31)
【24h】

Corrigendum to 'The Effects of Combination Therapy with Dutasteride and Tamsulosin on Clinical Outcomes in Men with Symptomatic Benign Prostatic Hyperplasia: 4-Year Results from the CombAT Study' (Eur Urol 2010;57:123-31)

机译:“度他雄胺和坦索罗辛联合治疗对有症状的良性前列腺增生症男性患者的临床结局的影响:CombAT研究的4年结果”(Eur Urol 2010; 57:123-31)勘误

获取原文
获取原文并翻译 | 示例
           

摘要

The first sentence of the first paragraph of section 3.2 should read:The time to first AUR or BPH-related surgery was significantly longer with combination therapy versus tamsulosin (p < 0.001); there was no significant difference between combination therapy and dutasteride (p = 0.18). The first sentence of the second paragraph of section 3.2 should read:When AUR and BPH-related surgery were considered separately, time to first event was significantly longer with combination therapy versus tamsulosin (p < 0.001).
机译:3.2节第一段的第一句应为:与坦索罗辛相比,联合疗法首次进行AUR或BPH相关手术的时间明显更长(p <0.001);联合疗法与度他雄胺之间无显着差异(p = 0.18)。 3.2节第二段的第一句应为:当分别考虑AUR和BPH相关手术时,与坦索罗辛相比,联合治疗的首次事件发生时间明显更长(p <0.001)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号